trending Market Intelligence /marketintelligence/en/news-insights/trending/gVgi9PoFnzrMluq8dqdR_w2 content esgSubNav
In This List

Allergan nears $2.47B acquisition of ZELTIQ

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Allergan nears $2.47B acquisition of ZELTIQ

Allergan PLC's $2.47 billion purchase of ZELTIQ Aesthetics Inc. was cleared under U.S. antitrust laws.

The deal's waiting period under the Hart-Scott-Rodino Act expired, bringing the companies closer to completion.

The merger acquisition is still subject to other customer closing conditions.